RSU vesting adds 71,839 shares to Precigen (PGEN) director’s holdings

Rhea-AI Filing Summary

PRECIGEN, INC. director James S. Turley reported the vesting and conversion of restricted stock units into common shares. On March 13, 2026, 71,839 restricted stock units vested in full and were exercised, delivering 71,839 shares of common stock at no cash exercise price.

Following this compensation-related transaction, Turley directly owned 685,417 shares of Precigen common stock. The filing reflects an increase in equity holdings through RSU vesting rather than any open-market purchase or sale.

Insider Trade Summary

71,839 shares exercised/converted

Mixed 2 txns

Insider Turley James S

Role Director

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units	71,839	$0.00	--
Exercise	Common Stock	71,839	$0.00	--

Holdings After Transaction: Restricted Stock Units — 0 shares (Direct); Common Stock — 685,417 shares (Direct)

Footnotes (1)

1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. The RSUs vested in full on March 13, 2026.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Turley James S

(Last) (First) (Middle)

20374 SENECA MEADOWS PARKWAY

(Street)

GERMANTOWN MD 20876

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
PRECIGEN, INC. [ PGEN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/13/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/13/2026		M		71,839	A	(1)	685,417	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	03/13/2026		M			71,839	(2)	(2)	Common Stock	71,839	$0	0	D

Explanation of Responses:

1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock.

2. The RSUs vested in full on March 13, 2026.

	/s/ James S. Turley, by Donald P. Lehr, as attorney-in-fact	03/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Precigen (PGEN) director James S. Turley report?

James S. Turley reported the vesting and conversion of restricted stock units into common shares. On March 13, 2026, 71,839 RSUs vested and were exercised, resulting in 71,839 new common shares, increasing his direct Precigen holdings to 685,417 shares.

How many Precigen (PGEN) shares did James S. Turley acquire through RSU vesting?

He acquired 71,839 shares of Precigen common stock through the vesting of an equal number of restricted stock units. Each RSU represented a contingent right to receive one share, and all vested in full on March 13, 2026, at a stated price of $0.00 per share.

What are restricted stock units (RSUs) in the context of Precigen (PGEN)?

For Precigen, each restricted stock unit represents a contingent right to receive one share of common stock. In this filing, RSUs granted to director James S. Turley fully vested on March 13, 2026, and were settled in 71,839 shares of Precigen common stock.

What is James S. Turley’s Precigen (PGEN) share ownership after the reported Form 4?

After the reported RSU vesting and share delivery, James S. Turley directly owned 685,417 shares of Precigen common stock. This total reflects the addition of 71,839 shares received upon full vesting and exercise of his restricted stock units on March 13, 2026.

Did the Precigen (PGEN) Form 4 show any open-market buying or selling by James S. Turley?

The Form 4 did not show any open-market purchases or sales. Instead, it reported a derivative exercise where 71,839 restricted stock units vested and converted into 71,839 common shares at a $0.00 exercise price, increasing his direct ownership to 685,417 shares.